pfizer glp-1 agonist pulls out of race after safety concerns Pfizer discontinues oral GLP-1 receptor

Fayetteville NC Ozempic Weight Loss Injections at Cape Fear Physical Medicine & Rehab

The Name Behind This Natural GLP-1

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

Learn why GLP-1 therapy alone often leads to muscle loss and regain.

Purpose of Review This review will summarize the most contemporary trials for glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2-i) and present guidance on management and recommendations on adjunctive tapering of insulin in patients with insulin-dependent diabetes mellitus, which we term de-insulinization. Recent Findings GLP1-RA and SGLT2-i are the principal classes of diabetes medications evidencing cardiovascular benefit